Track Latigo Biotherapeutics's net tangible assets ($390M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), LTGO shows a net tangible assets of $390M. Scroll down for historical charts and peer comparison views.
Tracking LTGO's net tangible assets over time shows whether Latigo Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $390M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this net tangible assets page, Stockcircle has Latigo Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $390M) with ownership activity and broader fundamentals.